Literature DB >> 8375482

Plasmodium falciparum sporozoite immunization protects against Plasmodium berghei sporozoite infection.

B J Sina1, V E do Rosario, G Woollett, K Sakhuja, M R Hollingdale.   

Abstract

Irradiated sporozoites are generally thought to elicit protective immune responses that are parasite stage and species specific. But immunization with Plasmodium falciparum sporozoites delivered by the bite of infected mosquitoes protects an average of 60% mice from Plasmodium berghei sporozoite infection. Protection appears to be specific as P. falciparum sporozoite-immunized mice protected against P. berghei remain susceptible to Plasmodium yoelii sporozoite infection. Passively transferred immunoglobulin from P. falciparum sporozoite-immunized mouse serum protected naive mice against challenge with P. berghei sporozoites, indicating that cross-protection is mediated, at least in part, by anti-sporozoite antibody. Antibody-mediated protection may not be due to cross-reaction between P. falciparum and P. berghei CS proteins because mice immunized with the recombinant P. falciparum CS protein repeat vaccine candidate, R32tet32, remain susceptible to P. berghei sporozoite infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8375482     DOI: 10.1006/expr.1993.1069

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  8 in total

1.  Strain-specific immunity induced by immunization with pre-erythrocytic stages of Plasmodium chabaudi.

Authors:  R L Culleton; M Inoue; S E Reece; S Cheesman; R Carter
Journal:  Parasite Immunol       Date:  2011-01       Impact factor: 2.280

Review 2.  Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one?

Authors:  Bruno Douradinha; Maria M Mota; Adrian J F Luty; Robert W Sauerwein
Journal:  Infect Immun       Date:  2007-12-03       Impact factor: 3.441

3.  Analysis of immune responses against T- and B-cell epitopes from Plasmodium falciparum liver-stage antigen 1 in rodent malaria models and malaria-exposed human subjects in India.

Authors:  S K Joshi; A Bharadwaj; S Chatterjee; V S Chauhan
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

4.  A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of Hep-G2 cells and protect immunized mice against P. berghei sporozoite challenge.

Authors:  S Chatterjee; M Wery; P Sharma; V S Chauhan
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

5.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

6.  A Plasmodium berghei sporozoite-based vaccination platform against human malaria.

Authors:  António M Mendes; Marta Machado; Nataniel Gonçalves-Rosa; Isaie J Reuling; Lander Foquet; Cláudia Marques; Ahmed M Salman; Annie S P Yang; Kara A Moser; Ankit Dwivedi; Cornelus C Hermsen; Belén Jiménez-Díaz; Sara Viera; Jorge M Santos; Inês Albuquerque; Sangeeta N Bhatia; John Bial; Iñigo Angulo-Barturen; Joana C Silva; Geert Leroux-Roels; Chris J Janse; Shahid M Khan; Maria M Mota; Robert W Sauerwein; Miguel Prudêncio
Journal:  NPJ Vaccines       Date:  2018-08-24       Impact factor: 7.344

7.  In vivo CD8+ T cell dynamics in the liver of Plasmodium yoelii immunized and infected mice.

Authors:  Mynthia Cabrera; Lecia L Pewe; John T Harty; Ute Frevert
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

Review 8.  The Case for Exploiting Cross-Species Epitopes in Malaria Vaccine Design.

Authors:  Catherine J Mitran; Stephanie K Yanow
Journal:  Front Immunol       Date:  2020-02-27       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.